Clinical Evaluation of SI-R21204 Versus Nano-hybrid Resin Composite: A Prospective Controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

August 16, 2020

Conditions
Caries
Interventions
DEVICE

SI-R21204 resin composite

Primary caries of posterior teeth will be restored using SI-R21204 resin composite. Procedures will be done under local anesthesia if necessary. The preperation and restoration of the tooth will be done according to to the guidelines for ordinary restorative techniques.

DEVICE

Nanohybrid resin composite

One of the cavities will be restored with a nanohybrid resin composite (Clearfil Majesty) as a control restoration wth ordinary restorative techniques.

Trial Locations (1)

34083

Istanbul Medipol University School of Dentistry, Istanbul

All Listed Sponsors
collaborator

Shofu Inc.

INDUSTRY

lead

Istanbul Medipol University Hospital

OTHER

NCT02823769 - Clinical Evaluation of SI-R21204 Versus Nano-hybrid Resin Composite: A Prospective Controlled Clinical Trial | Biotech Hunter | Biotech Hunter